Clinical trial
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe…
NCT00147199 · United Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00147199 |
|---|---|
| Title | Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) |
| Official title | TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension |
| Acronym | TRIUMPH |
| Lead sponsor | United Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Inhaled treprostinil, Placebo inhalation solution |
| Enrollment | 235 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 2, 2024 |
| Countries | Austria, Belgium, France, Germany, Ireland, Israel, Italy, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: